Home > Boards > Free Zone > User's Groups > Mega Cap Ideas

Johnson & Johnson - >>> 4 Top Stocks

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
gfp927z Member Profile
 
Followed By 70
Posts 25,882
Boards Moderated 75
Alias Born 03/22/05
160x600 placeholder
Top Company News of the Day
The waiver allows Credit Suisse's investment adviser affiliates to keep doing business following an SEC settlement, but the Republican says some requirements could be harmful.
Canada Antitrust Watchdog Probes Google Conduct in Online Ad Market -- Update
Canada Antitrust Watchdog Probes Google Conduct in Online Ad Market
USDA Reports Drop in Cattle Placed on Market
Wheat Rises on Tighter Supply Picture -- Daily Grain Highlights
Warren Buffett Tenders Cattolica Stake as Generali Takeover Edges Closer, Source Says
Front Month Nymex Natural Gas Fell 2.40% This Week to Settle at $5.2800 -- Data Talk
Front Month Nymex RBOB Gasoline Fell 0.17% This Week to Settle at $2.4821 -- Data Talk
Trustmark National Bank To Pay $5 Million To Settle Lending Discrimination Claims
3Q GDP Seen +3.0% -- Data Week Ahead
U.S. Oil-Rig Count Falls by Two in Latest Week, Baker Hughes Says
American Express on Track for Record High Close -- Data Talk
UK Takeover Panel Suspends Timetable on Ganfeng's Offer for Bacanora Lithium
S&P Global, IHS Markit Get Conditional Approval From European Commission for Deal
FTSE 100 Closed Up as It Shrugs off the Week's Negative Sentiment
STOXX Europe 50 Index Ends the Week 0.25% Higher at 3637.18 -- Data Talk
EURO STOXX 50 Index Ends the Week 0.14% Higher at 4188.81 -- Data Talk
STOXX Europe 600 Index Ends the Week 0.53% Higher at 471.88 -- Data Talk
FTSE 100 Index Ends the Week 0.41% Lower at 7204.55 -- Data Talk
DAX Ends the Week 0.28% Lower at 15542.98 -- Data Talk
CAC 40 Index Ends the Week 0.09% Higher at 6733.69 -- Data Talk
S&P Global's Acquisition of IHS Markit Gets Conditional Green Light From EU
Walmart on Track for Longest Winning Streak Since September 2019 -- Data Talk
Snap Inc. Down Over 23%, on Track for Record Percent Decrease -- Data Talk
Watchdog Criticizes FAA Oversight Of American Airlines Maintenance
Creatd Shares Jump After Unit Signs Alexis LaRue
gfp927z   Thursday, 09/02/21 10:57:02 AM
Re: None
Post # of 27 
Johnson & Johnson - >>> 4 Top Stocks to Buy and Hold for the Next Decade

These stocks could grow exponentially in coming years.


Motley Fool

by Neha Chamaria

Aug 28, 2021


https://www.fool.com/investing/2021/08/28/4-top-stocks-to-buy-and-hold-for-the-next-decade/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article


Key Points

Investing in high-growth industries is the key to making money.
Utilities are safe investments, but some are also tremendous growth stocks.

Healthcare and clean energy offer mind-boggling investing opportunities right now.


COVID-19 vaccine could be a shot in the arm for this Dividend King


Johnson & Johnson (NYSE:JNJ) stock has proven to be a stellar performer for patient investors over the years, and that's unlikely to change.

Johnson & Johnson is a leader in the healthcare space with an exemplary mix of businesses -- while its globally renowned consumer health brands generate steady cash flows, its larger pharmaceuticals and medical devices businesses offer unending growth opportunities.

Just to give you some examples, several of Johnson & Johnson's products received regulatory approvals last quarter, including drugs for lung cancer, sclerosis, and myeloma, and a next-generation treatment procedure for cataract.

Johnson & Johnson's growth strategy has clicked so far because it has always prioritized organic growth via consistent spending on research and development (R&D), and spent remaining free cash flows on acquisitions, dividends, and share repurchases. So in 2020, it invested $12.2 billion in R&D, and paid out $10.5 billion in dividends.

In fact, Johnson & Johnson mainly lures investors with its dividends -- it's one of the best Dividend Kings to own, having increased dividends every year for 59 consecutive years. The stock yields a respectable 2.4%.

Now that Johnson & Johnson's single-shot COVID-19 vaccine could also potentially generate big sales, it's a stock you'd want to own for decades.

<<<




Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences